查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049605

瘧疾診斷市場報告：按技術、應用和地區分類（2026-2034 年）

Malaria Diagnostics Market Report by Technology (Microscopy, Rapid Diagnostic Tests (RDTs), Molecular Diagnostic Tests), End Use (Hospital, Clinics, Diagnostic Centers), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年全球瘧疾診斷市場規模達9.246億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到14.862億美元，2026年至2034年的複合年成長率為5.25%。

瘧疾診斷是指透過臨床檢測來判斷個體是否感染瘧疾。瘧疾是由受感染的雌性阿諾菲蚊叮咬引起的，瘧疾原蟲因此進入人體。常見症狀包括發燒、疲倦、噁心和頭痛。感染疾病的診斷方法包括多種快速診斷方法、顯微鏡檢查和分子診斷檢測。這些檢測方法採用抗原檢測和血清學方法，例如間接螢光（IFA）和酵素免疫分析法（ELISA）。這些方法廣泛應用於醫院、檢查室、診所、研究機構和診斷中心。

瘧疾診斷市場趨勢：

瘧疾的全球蔓延是推動市場前景光明的主要因素之一。瘧疾是一種危及生命的感染疾病，已造成大量生命逝去，尤其是在開發中國家。然而，公眾對瘧疾診斷和治療方法意識的提高正在推動市場成長。顯微鏡診斷廣泛應用於醫療機構和診斷檢查室，用於識別瘧原蟲的各個發育階段並制定相應的治療方案。此外，各種技術進步，例如用於瘧疾診斷的定量白血球層（QBC）和周邊血液抹片方法的開發，也在推動市場成長。同時，即時診斷（POC）設備的普及提高了診斷準確性，也促進了市場成長。此外，公眾醫療支付能力的提高以及政府為促進公共衛生而實施的利好政策，預計也將推動市場成長。

本報告解答的主要問題

  • 全球瘧疾診斷市場規模有多大？
  • 2026年至2034年全球瘧疾診斷市場的預期成長率為何？
  • 推動全球瘧疾診斷市場發展的主要因素有哪些？
  • 新冠疫情對全球瘧疾診斷市場產生了哪些影響？
  • 從技術角度來看，全球瘧疾診斷市場是如何細分的？
  • 全球瘧疾診斷市場依最終用途分類是怎樣的？
  • 全球瘧疾診斷市場的主要地區有哪些？
  • 全球瘧疾診斷市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球瘧疾診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依技術分類

  • 顯微鏡
  • 快速診斷檢測（RDT）
  • 分子診斷測試
    • 主要部分
      • 常規PCR
      • 即時PCR（qPCR）

第7章 市場區隔：依最終用途分類

  • 醫院
  • 診所
  • 診斷中心

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Access Bio
    • Beckman Coulter Inc.（Danaher Corporation）
    • bioMerieux SA（Compagnie Merieux Alliance）
    • Bio-Rad Laboratories Inc.
    • Nikon Corporation
    • Novartis AG
    • Olympus Corporation
    • Premier Medical Corporation Pvt. Ltd.
    • Siemens Healthcare GmbH（Siemens AG）
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc
Product Code: SR112026A3896

The global malaria diagnostics market size reached USD 924.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,486.2 Million by 2034, exhibiting a growth rate (CAGR) of 5.25% during 2026-2034.

Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

MALARIA DIAGNOSTICS MARKET TRENDS:

The increasing prevalence of malaria across the globe is one of the key factors creating a positive outlook for the market. Malaria is a life-threatening infection that has caused a significant loss of human lives, especially in developing nations. However, rising awareness among the masses regarding the available diagnostic and treatment alternatives for malaria is providing a thrust to the market growth. Healthcare centers and diagnostic laboratories are widely adopting microscopic diagnostics to identify the parasite at different stages and design suitable treatment plans. Additionally, various technological advancements, such as the development of the Quantitative Buffy Coat (QBC) method and peripheral blood smear technique for diagnosing malaria, are acting as other growth-inducing factors. In line with this, the availability of Point-of-Care (POC) diagnostic devices for enhanced accuracy is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

KEY MARKET SEGMENTATION:

Breakup by Technology:

  • Microscopy
  • Rapid Diagnostic Tests (RDTs)
  • Molecular Diagnostic Tests
    • Conventional PCR
    • Real-Time PCR (qPCR)

Breakup by End Use:

  • Hospital
  • Clinics
  • Diagnostic Centers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.How big is the global malaria diagnostics market?
  • 2.What is the expected growth rate of the global malaria diagnostics market during 2026-2034?
  • 3.What are the key factors driving the global malaria diagnostics market?
  • 4.What has been the impact of COVID-19 on the global malaria diagnostics market?
  • 5.What is the breakup of the global malaria diagnostics market based on the technology?
  • 6.What is the breakup of the global malaria diagnostics market based on the end use?
  • 7.What are the key regions in the global malaria diagnostics market?
  • 8.Who are the key players/companies in the global malaria diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Malaria Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Microscopy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rapid Diagnostic Tests (RDTs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Molecular Diagnostic Tests
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Conventional PCR
      • 6.3.2.2 Real-Time PCR (qPCR)
    • 6.3.3 Market Forecast

7 Market Breakup by End Use

  • 7.1 Hospital
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diagnostic Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Access Bio
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 bioMerieux SA (Compagnie Merieux Alliance)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Bio-Rad Laboratories Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Nikon Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Novartis AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Olympus Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Premier Medical Corporation Pvt. Ltd.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Siemens Healthcare GmbH (Siemens AG)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sysmex Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Thermo Fisher Scientific Inc
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Malaria Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Malaria Diagnostics Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Malaria Diagnostics Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Malaria Diagnostics Market: Breakup by End Use (in %), 2025
  • Figure 6: Global: Malaria Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Malaria Diagnostics (Microscopy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Malaria Diagnostics (Microscopy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Malaria Diagnostics (Rapid Diagnostic Tests (RDTs)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Malaria Diagnostics (Rapid Diagnostic Tests (RDTs)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Malaria Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Malaria Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Malaria Diagnostics (Hospital) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Malaria Diagnostics (Hospital) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Malaria Diagnostics (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Malaria Diagnostics (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Malaria Diagnostics (Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Malaria Diagnostics (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: North America: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: North America: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: United States: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: United States: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Canada: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Canada: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Asia-Pacific: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Asia-Pacific: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: China: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: China: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Japan: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Japan: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: India: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: India: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: South Korea: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: South Korea: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Australia: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Australia: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Indonesia: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Indonesia: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Others: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Europe: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Europe: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Germany: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Germany: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: France: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: France: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: United Kingdom: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: United Kingdom: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Italy: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Italy: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Spain: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Spain: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Russia: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Russia: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Others: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Latin America: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Latin America: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Brazil: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Brazil: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Mexico: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Mexico: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Middle East and Africa: Malaria Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Middle East and Africa: Malaria Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 67: Middle East and Africa: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Global: Malaria Diagnostics Industry: SWOT Analysis
  • Figure 69: Global: Malaria Diagnostics Industry: Value Chain Analysis
  • Figure 70: Global: Malaria Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Malaria Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Malaria Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 3: Global: Malaria Diagnostics Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 4: Global: Malaria Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Malaria Diagnostics Market: Competitive Structure
  • Table 6: Global: Malaria Diagnostics Market: Key Players